C08B 37/0009
Alpha-d-glucans
Official title: {alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof}
C08B37/0009 (Alpha-d-glucans) appears on 1,535 US grants and 1,715 published applications in this corpus.
Search patents in C08B- Granted patents
- 1,535
- Published applications
- 1,715
- Assignees
- 967
- Inventors
- 3,675
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 10 | 0 |
| 1978 | 9 | 0 |
| 1979 | 7 | 0 |
| 1980 | 4 | 0 |
| 1981 | 7 | 0 |
| 1982 | 6 | 0 |
| 1983 | 9 | 0 |
| 1984 | 10 | 0 |
| 1985 | 11 | 0 |
| 1986 | 16 | 0 |
| 1987 | 16 | 0 |
| 1988 | 26 | 0 |
| 1989 | 19 | 0 |
| 1990 | 28 | 0 |
| 1991 | 22 | 0 |
| 1992 | 20 | 0 |
| 1993 | 27 | 0 |
| 1994 | 16 | 0 |
| 1995 | 22 | 0 |
| 1996 | 34 | 0 |
| 1997 | 43 | 0 |
| 1998 | 46 | 0 |
| 1999 | 26 | 0 |
| 2000 | 24 | 0 |
| 2001 | 18 | 6 |
| 2002 | 21 | 30 |
| 2003 | 36 | 44 |
| 2004 | 23 | 38 |
| 2005 | 25 | 34 |
| 2006 | 25 | 39 |
| 2007 | 14 | 38 |
| 2008 | 14 | 35 |
| 2009 | 18 | 54 |
| 2010 | 23 | 66 |
| 2011 | 18 | 56 |
| 2012 | 28 | 64 |
| 2013 | 54 | 88 |
| 2014 | 41 | 64 |
| 2015 | 42 | 89 |
| 2016 | 59 | 87 |
| 2017 | 57 | 93 |
| 2018 | 57 | 105 |
| 2019 | 88 | 99 |
| 2020 | 98 | 105 |
| 2021 | 81 | 108 |
| 2022 | 59 | 84 |
| 2023 | 54 | 85 |
| 2024 | 43 | 80 |
| 2025 | 49 | 76 |
| 2026 | 26 | 48 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same6 Oct 2026US 12,753,248 B2Beren Therapeutics P.B.C.
- Polysaccharide derivatives for detergent compositions15 Sep 2026US 12,735,511 B2
- Compositions comprising insoluble alpha-glucan25 Aug 2026US 12,715,981 B2Nutrition & Biosciences USA 4, Inc.
- Hair oil formulation4 Aug 2026US 12,697,294 B2Dow Global Technologies LLC
- Alkylated cyclodextrin compositions and processes for preparing and using the same4 Aug 2026US 12,698,348 B2CyDex Pharmaceuticals, Inc.
- Pharmaceutical compositions comprising meloxicam8 Oct 2026US 2026/0306635 A1Axsome Therapeutics, Inc.
- Porous alpha-1,3-glucan compositions8 Oct 2026US 2026/0308347 A1Nutrition & Biosciences USA 4, Inc.
- Lithography method8 Oct 2026US 2026/0310079 A1Taiwan Semiconductor Manufacturing Company.Ltd
- Amphiphilic glucan ester derivatives1 Oct 2026US 2026/0294778 A1Nutrition & Biosciences USA 4, Inc.
- Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the same13 Aug 2026US 2026/0234294 A1Beren Therapeutics P.B.C.
Most cited
By later US patents
- Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof419US 5,134,127 AUniversity of Kansas · 1992
- Pharmaceutical preparations containing cyclodextrin derivatives406US 4,727,064 AThe United States of America as represented by the Department of Health and Human Services · 1988
- Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof346US 5,376,645 AUniversity of Kansas · 1994
- Cyclodextrin polymers for carrying and releasing drugs324US 6,048,736 A2000
- Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof308US 4,757,141 AApplied Biosystems, LLC · 1988